United Biotech Private Limited Gefitinib Export Data — India (DGFT 2022–2026)

Name: United Biotech Private Limited Gefitinib Export Records India — #7 Exporter, 15 Shipments, $45.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Gefitinib

India Pharmaceutical Trade Intelligence

$6.8M80 Suppliers47 CountriesHS 30049049

ExportsIndia → BRAZIL41.7%India → IRAQ34.9%

ImportsUNITED STATES → India$67.4K JAPAN → India$42.0K

#1 Supplier: CIPLA LIMITED

United Biotech Private Limited — Gefitinib Exporter #7 | $45.6K Trade Value | TransData Nexus | TransData Nexus

United Biotech Private Limited — Gefitinib Exporter Profile

Indian Pharmaceutical Exporter · #7 for Gefitinib · $45.6K export value · DGFT Verified

United Biotech Private Limited is the #7 Indian exporter of Gefitinib with $45.6K in export value and 15 verified shipments. United Biotech Private Limited holds a 0.7% market share in Gefitinib exports across 4 countries. The company exports 30 pharmaceutical products worth $7.0M across 7 therapeutic categories.

United Biotech Private Limited — Gefitinib Export Profile: Buyers & Destinations

United Biotech Private Limited Gefitinib export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Gefitinib?

Country	Value	Shipments	Share
BRAZIL	$950.0K	19	36.7%
IRAQ	$450.0K	9	17.4%
PHILIPPINES	$374.1K	21	14.5%
MYANMAR	$149.0K	13	5.8%

Who Are the Top Buyers of Gefitinib from India?

Buyer	Country	Value	Orders
CIPLA BRASIL IMPORTADORA E	BRAZIL	$400.0K	8
THE MODERN CO	IRAQ	$300.0K	6
NATCO LIFESCIENCES PHILLIPINES INC	PHILIPPINES	$170.6K	4
CIPLA BRASIL IMPORTADORA E DISTRIBUIDORA DE MEDICAMENTOS LTD	BRAZIL	$138.5K	3
NATCOFARMA DO BRASIL LTDA	BRAZIL	$100.0K	2
NATCOFARMA DO BRASIL LTDA,	BRAZIL	$100.0K	2
OOOJODAS EXPOIM	RUSSIA	$100.0K	2
NATCO LIFESCIENCES PHILIPPINES	PHILIPPINES	$100.0K	2
NI LAY NAING CO.LTD..	MYANMAR	$67.4K	6
NI LAY NAING CO. LTD	MYANMAR	$48.9K	3

India's Gefitinib is purchased by 135 buyers worldwide. The top buyer is CIPLA BRASIL IMPORTADORA E (BRAZIL), followed by THE MODERN CO and NATCO LIFESCIENCES PHILLIPINES INC.

How Does United Biotech Private Limited Compare to Nearest Gefitinib Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	KHANDELWAL LABORATORIES PRIVATE LIMITED	$139.8K	11	1	$12.7K
6	PROSPERA LIFE SCIENCES PRIVATE LIMITED	$47.4K	26	4	$1.8K
7	UNITED BIOTECH PRIVATE LIMITED ★	$45.6K	15	4	$3.0K
8	VEXXA LIFESCIENCES PVT. LTD.	$45.6K	8	1	$5.7K
9	ASPIDA LIFE SCIENCES PRIVATE LIMITED	$39.0K	16	3	$2.4K

United Biotech Private Limited ranks #7 among 80 Indian Gefitinib exporters. Average shipment value of $3.0K compared to the market average of $32.6K. The closest competitors by value are KHANDELWAL LABORATORIES PRIVATE LIMITED and PROSPERA LIFE SCIENCES PRIVATE LIMITED.

Which Indian Ports Ship Gefitinib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	72	24.2%
SAHAR AIR	56	18.9%
DELHI AIR CARGO ACC (INDEL4)	34	11.4%
DELHI AIR	25	8.4%
Bombay Air	23	7.7%
AHEMDABAD AIR	11	3.7%
Delhi Air	10	3.4%
HYDERABAD AIR	10	3.4%

Geopolitical & Trade Policy Impact on United Biotech Private Limited's Gefitinib Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like United Biotech. The Israel-Iran conflict has escalated tensions in the Middle East, leading to disruptions in Red Sea shipping routes and increased freight costs. The Pharmaceuticals Export Promotion Council of India estimates potential losses between ₹2,500 crore and ₹5,000 crore due to these disruptions, affecting companies reliant on Middle Eastern markets. (telanganatoday.com)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical firms to expand their footprint in the American market. However, recent U.S. tariff policies, including potential increases on pharmaceutical imports, pose a risk to this growth. President Trump's administration has threatened substantial tariff hikes to encourage domestic production, which could impact Indian exporters' competitiveness in the U.S. market. (lemonde.fr)

In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures for exporters. Indian companies must adapt to these regulatory changes to maintain access to the EU market. The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade, potentially benefiting exporters like United Biotech. (en.wikipedia.org)

United Biotech Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set rigorous quality benchmarks that companies must meet to access global markets. While specific regulatory events concerning United Biotech are not detailed, adherence to these standards is essential for sustaining export operations.

The evolving quality requirements, including serialization and traceability mandates under the EU FMD, necessitate continuous investment in compliance infrastructure. Indian exporters must proactively adapt to these changes to ensure uninterrupted market access and maintain their reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gefitinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: United Biotech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 47+ countries, 135+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gefitinib

Gefitinib

United Biotech Private Limited — Gefitinib Exporter Profile

United Biotech Private Limited — Gefitinib Export Profile: Buyers & Destinations

Where Does India Export Gefitinib?

Who Are the Top Buyers of Gefitinib from India?

What Is India's Total Gefitinib Export Value and How Much Does United Biotech Private Limited Contribute?

What Is the Average Shipment Value for United Biotech Private Limited's Gefitinib Exports?

How Does United Biotech Private Limited Compare to Other Indian Gefitinib Exporters?

Regulatory Requirements: Exporting Gefitinib to Key Markets

Brazil — ANVISA

How Does United Biotech Private Limited Compare to Nearest Gefitinib Exporters?

Which Indian Ports Ship Gefitinib Exports?

What Other Advanced Oncology Products Does United Biotech Private Limited Export?

Geopolitical & Trade Policy Impact on United Biotech Private Limited's Gefitinib Exports

United Biotech Private Limited — Regulatory Compliance & Quality Standards

About United Biotech Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gefitinib Export Data from United Biotech Private Limited

Gefitinib Stats

Company Overview

Top Products by United Biotech Private Limited

Related Analysis

Need Detailed Export Data?

Data Source